The Department of Defense (DOD) Drug Demand Reduction Program (DDRP) seeks proposals for a WADA-accredited laboratory to conduct performance-enhancing drug testing for the U.S. Army. This contract focuses on urinalysis testing for substances on the WADA prohibited list, with a base period of 12 months and two optional 12-month extensions. The laboratory must perform up to 840 base tests, with potential increases, and provide expedited testing results within 7 to 10 business days.
The contract outlines comprehensive requirements, including subject matter expert consultation, batch processing capabilities, adherence to quality assurance and regulatory standards, and proper record keeping for three years. Laboratories must comply with all guidelines from relevant authorities and are required to maintain specimen integrity throughout the testing process.
Additional provisions include mandatory participation in WADA proficiency programs, retention times for positive samples, and detailed reporting obligations for test results. Inspections by DDRP will occur twice a year to ensure compliance. This RFP emphasizes the importance of integrity and scientific validity in drug testing, reflecting the DOD's commitment to maintaining high standards in personnel health and performance.
The U.S. Army Special Operations Command (USASOC) is conducting market research to identify potential sources for providing comprehensive services related to Performance Enhancing Drug (PED) testing, specifically for analyzing human urine specimens for anabolic steroids. Interested vendors should be accredited by the World Anti-Doping Agency (WADA) and able to meet the specifications in the attached DRAFT Statement of Work (SOW). This Sources Sought Notice is a preliminary step before a formal solicitation, aimed at gathering information about business capabilities, particularly from small businesses. Interested parties are asked to submit their company information, socioeconomic status, and a brief statement of capability, addressing specific questions related to their ability to conduct WADA-standard tests, isotope ratio mass spectrometry, and provide expert analysis. The anticipated period of performance is a 12-month base period with four optional one-year extensions. The applicable NAICS code is 541380 for Testing Laboratories and Services. Responses to this notice are voluntary, with no costs reimbursed, and must be submitted by March 3, 2025.